KODIAK SCIENCES INC. Earnings Per Share (Diluted)
KODIAK SCIENCES INC. (KOD) reported Earnings Per Share (Diluted) of -$1.05 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-13
- KODIAK SCIENCES INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$1.05.
- KODIAK SCIENCES INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.94.
- KODIAK SCIENCES INC. earnings per share, diluted for the quarter ending 2025-12-31 was -$1.04.
- KODIAK SCIENCES INC. earnings per share, diluted for the quarter ending 2025-09-30 was -$1.16.
- KODIAK SCIENCES INC. earnings per share, diluted for fiscal 2025 was -$4.32.
- KODIAK SCIENCES INC. earnings per share, diluted for fiscal 2024 was -$3.35.
- KODIAK SCIENCES INC. earnings per share, diluted for fiscal 2023 was -$4.97.
- KODIAK SCIENCES INC. earnings per share, diluted for fiscal 2022 was -$6.39.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.05 10-Q · filed 2026-08-13 | -$1.99 10-Q · filed 2026-08-13 | -$3.03 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$4.18 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2026-03-31 | -$0.94 10-Q · filed 2026-05-07 | -$1.98 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$3.13 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$4.16 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-12-31 | -$1.04 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$2.20 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$3.23 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$4.32 10-K · filed 2026-03-31 |
| 2025-09-30 | -$1.16 10-Q · filed 2025-11-13 | -$2.19 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$3.28 10-Q · filed 2025-11-13 | -$4.12 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-06-30 | -$1.03 10-Q · filed 2026-08-13 | -$2.12 10-Q · filed 2026-08-13 | -$2.96 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$3.79 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-03-31 | -$1.09 10-Q · filed 2026-05-07 | -$1.93 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.76 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$3.62 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2024-12-31 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.67 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$2.53 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$3.35 10-K · filed 2026-03-31 |
| 2024-09-30 | -$0.84 10-Q · filed 2025-11-13 | -$1.69 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$2.51 10-Q · filed 2025-11-13 | -$3.65 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2024-06-30 | -$0.86 10-Q · filed 2025-08-13 | -$1.68 10-Q · filed 2025-08-13 | -$2.81 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$3.77 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2024-03-31 | -$0.82 10-Q · filed 2025-05-14 | -$1.95 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$2.91 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$4.44 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2023-12-31 | -$1.13 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$2.09 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$3.62 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$4.97 10-K · filed 2026-03-31 |
| 2023-09-30 | -$0.95 10-Q · filed 2024-11-14 | -$2.48 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$3.84 10-Q · filed 2024-11-14 | -$5.18 derived: net income ÷ weighted average shares · filed 2025-03-27 |
| 2023-06-30 | -$1.53 10-Q · filed 2024-08-14 | -$2.88 10-Q · filed 2024-08-14 | -$4.23 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$5.70 derived: net income ÷ weighted average shares · filed 2025-03-27 |
| 2023-03-31 | -$1.35 10-Q · filed 2024-05-15 | -$2.70 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$4.17 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$5.91 derived: net income ÷ weighted average shares · filed 2025-03-27 |
| 2022-12-31 | -$1.35 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$2.82 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$4.56 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$6.39 10-K · filed 2025-03-27 |
| 2022-09-30 | -$1.47 10-Q · filed 2023-11-14 | -$3.21 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$5.04 10-Q · filed 2023-11-14 | -$6.83 derived: net income ÷ weighted average shares · filed 2024-03-28 |
| 2022-06-30 | -$1.74 10-Q · filed 2023-08-14 | -$3.57 10-Q · filed 2023-08-14 | -$5.36 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$6.67 derived: net income ÷ weighted average shares · filed 2024-03-28 |
| 2022-03-31 | -$1.83 10-Q · filed 2023-05-15 | -$3.63 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$4.93 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$6.02 derived: net income ÷ weighted average shares · filed 2024-03-28 |
| 2021-12-31 | -$1.79 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$3.09 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$4.18 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$5.16 10-K · filed 2024-03-28 |
| 2021-09-30 | -$1.30 10-Q · filed 2022-11-09 | -$2.39 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$3.36 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$1.08 10-Q · filed 2022-08-09 | -$2.06 10-Q · filed 2022-08-09 | ||
| 2020-12-31 | -$2.91 10-K · filed 2023-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |